The role of the mitochondrial permeability transition pore in neurodegenerative processes;Papel del poro de permeabilidad transitoria mitocondrial en los procesos neurodegenerativos

Revista de Neurologia

Volumn 35, Issue 4, 2002, Pages 354-361

  Tornero, D ^a   Cena V ^a   Gonzalez Garcia C ^a   Jordán, Joaquin ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Apoptosis; Bcl 2; Calcium; Caspase; Cytochrome c; Oxygen reactive species

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CALCIUM ION; CASPASE; CYTOCHROME C; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; CARRIER PROTEIN; ION CHANNEL;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN MITOCHONDRION; CHANNEL GATING; DEGENERATIVE DISEASE; ELECTROCHEMICAL ANALYSIS; HEREDITY; MITOCHONDRIAL MEMBRANE; PARKINSON DISEASE; PRION DISEASE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL DEATH; HUMAN; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; SECOND MESSENGER;

ANIMALS; APOPTOSIS; CELL DEATH; HUMANS; ION CHANNELS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NEURODEGENERATIVE DISEASES; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 0037119563     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3504.2002389     Document Type: Review

References (84)

1. Bereiter-Hahn J. Behavior of mitochondria in the living cell. Int Rev Cytol 1990; 122: 1-63.
2. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-9.
3. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
4. Gray MW, Burger G, Lang BF. Mitochondrial evolution. Science 1999; 283: 1476-81.
5. DePierre JW, Ernster L. Enzyme topology of intracellular membranes. Annu Rev Biochem 1977; 46: 201-62.
6. Neupert W. Protein import into mitochondria. Annu Rev Biochem 1997; 66: 863-917.
7. Schatz G, Dobberstein B. Common principles of protein translocation across membranes. Science 1996; 271: 1519-26.
8. Johnson N, Khan A, Virji S, Ward JM, Crompton M. Import and processing of heart mitochondrial cyclophilin D. Eur J Biochem 1999; 263: 353-9.
9. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 1985; 54: 1015-69.
10. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 1999; 283: 1488-93.
11. Skulachev VP. Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. Mol Aspects Med 1999; 20: 139-84.
12. + antiport activity in yeast mitochondria. J Biol Chem 2001; 276: 40502-9.
13. 2+ revealed by specifically targeted recombinant aequorin. Nature 1992; 358: 325-7.
14. Wang GJ, Thayer SA. NMDA-induced calcium loads recycle across the mitochondrial inner membrane of hippocampal neurons in culture. J Neurophysiol 2002; 87: 740-9.
15. 2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 1993; 262: 744-7.
16. Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol 2000; 529: 37-47.
17. Bindokas VP, Jordán J, Lee CC, Miller RJ. Superoxide production in rat hippocampal neurons: Selective imaging with hydroethidine. J Neurosci 1996; 16: 1324-36.
18. Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 2002; 80: 780-7.
19. Murphy AN, Fiskum G, Beal MF. Mitochondria in neurodegeneration: Bioenergetic function in cell life and death. J Cereb Blood Flow Metab 1999; 19: 231-45.
20. Newmeyer DD, Farschon DM, Reed JC. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 1994; 79:353-64.
21. White RJ, Reynolds IJ. Mitochondrial depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure. J Neurosci 1996; 16: 5688-97.
22. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
23. Grinberg M, Sarig R, Zaltsman Y, Frumkin D, Grammatikakis N, Reuveny E, et al. tBid homooligomerizes in the mitochondrial membrane to induce apoptosis. J Biol Chem 2002; 277: 12237-45.
24. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L, et al. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: Protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 2002; 156: 531-42.
25. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 2000; 529: 11-21.
26. Andreeva L, Heads R, Green CJ. Cyclophilins and their possible role in the stress response. Int J Exp Pathol 1999; 80: 305-15.
27. Papadopoulos V, Dharmarajan AM, Li H, Culty M, Lemay M, Sridaran R. Mitochondrial peripheral-type benzodiazepine receptor expression. Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum. Biochem Pharmacol 1999; 58: 1389-93.
28. Yoshizaki K, Watari H, Radda GK. Role of phosphocreatine in energy transport in skeletal muscle of bullfrog studied by 31P-NMR. Biochim Biophys Acta 1990; 1051: 144-50.
29. Patterson SD, Spahr CS, Daugas E, Susin SA, Irinopoulou T, Koehler C, et al. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ 2000; 7: 137-44.
30. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000; 102: 43-53.
31. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-6.
32. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189: 381-94.
33. Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie Z, Deveraux QL, et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A 1999; 96: 5752-7.
34. Atlante A, Calissano P, Bobba A, Azzariti A, Marra E, Passarella S. Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death. J Biol Chem 2000; 275: 37159-66.
35. Jordán J, Galindo MF, Tornero D, Benavides A, González C, Agapito MT, et al. Superoxide anions mediate veratridine-induced cytochrome c release and caspase activity in bovine chromaffin cells. Br J Pharmacol 2002 [en prensa].
36. Sakurai K, Stoyanovsky DA, Fujimoto Y, Cederbaum Al. Mitochondrial permeability transition induced by 1-hydroxyethyl radical. Free Radic Biol Med 2000; 28: 273-80.
37. 2+-mediated mitochondrial dysfunction in neural cell death. Biochem Soc Symp 1999; 66: 33-41.
38. Murphy RC, Schneider E, Kinnally KW. Overexpression of Bcl-2 suppresses the calcium activation of a mitochondrial megachannel. FEBS Lett 2001; 497: 73-6.
39. 2+ homeostasis by Bcl-2. J Biol Chem 1999; 274: 33267-73.
40. Costantini P, Belzacq AS, Vieira HL, Larochette N, De Pablo MA, Zamzami N, et al. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 2000; 19: 307-14.
41. Shimizu S, Konishi A, Kodama T, Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci U S A 2000; 97: 3100-5.
42. Kostic V, Jackson-Lewis V, De Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997; 277: 559-62.
43. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 1999; 5: 347-50.
44. Prehn JH, Bindokas VP, Jordán J, Galindo MF, Ghadge GD, Roos RP, et al. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 1996; 49: 319-28.
45. L independently regulate apoptotic changes of yeast mitocbondria that require VDAC but not adenine nucleotide translocator. Oncogene 2000; 19: 4309-18.
46. Von Ahsen O, Renken C, Perkins G, Kluck RM, Bossy-Wetzel E, Newmeyer DD. Preservation of mitochondrial structure and function after Bid- or Bax-mediated cytochrome c release. J Cell Biol 2000; 150: 1027-36.
47. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A. 1998; 95: 4997-5002.
48. Brenner C, Cadiou H, Vieira HL, Zamzami N, Marzo I, Xie Z, et al. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 2000; 19: 329-36.
49. L. J Biol Chem 1999; 274: 2225-33.
50. L sequester BH3 domain-only molecules preventing Bax-and Bak-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705-11.
51. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 2000; 345: 271-8.
52. Heibein JA, Goping IS, Barry M, Pinkoski MJ, Shore GC, Green DR, et al. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J Exp Med 2000; 192: 1391-402.
53. Zamzami N, El Hamel C, Maisse C, Brenner C, Muñoz-Pinedo C, Belzacq AS, et al. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 2000; 19: 6342-50.
54. Shimizu S, Ide T, Yanagida T, Tsujimoto Y. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J Biol Chem 2000; 275: 12321-5.
55. Eskes R, Desagher S, Antonsson B, Martinou JC. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 2000; 20: 929-35.
56. Shimizu S, Tsujimoto Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc Natl Acad Sci U S A 2000; 97: 577-82.
57. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-31.
58. Majumder PK, Pandey P, Sun X, Cheng K, Datta R, Saxena S, et al. Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem 2000; 275: 21793-6.
59. Ferri KF, Jacotot E, Blanco J, Este JA, Kroemer G. Mitochondrial control of cell death induced by HIV-1-encoded proteins. Ann N Y Acad Sci 2000; 926: 149-64.
60. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 2000; 275: 16202-12.
61. Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 2000; 289: 1159-64.
62. Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 2000; 191: 33-46.
63. Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 2002; 54: 101-27.
64. Crompton M, Virji S, Ward JM. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem 1998; 258: 729-35.
65. Budd SL, Tenneti L, Lishnak T, Lipton SA. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci U S A 2000; 97: 6161-6.
66. Mattson MP, Duan W, Pedersen WA, Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 2001; 6: 69-81.
67. Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 1997; 16: 345-51.
68. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mom M, Fernández P, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973-83.
69. Wallace DC. A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 2001; 235: 247-66.
70. Treem WR, Sokol RJ. Disorders of the mitochondria. Semin Liver Dis 1998; 18: 237-53.
71. Brown MD, Trounce IA, Jun AS, Allen JC, Wallace DC. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. J Biol Chem 2000; 275: 39831-6.
72. Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J Neurochem 1997; 68: 1221-33.
73. Langston JW, Irwin I, Ricaurte GA. Neurotoxins, parkinsonism and Parkinson's disease. Pharmacol Ther 1987; 32: 19-49.
74. Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF, et al. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 1999; 5: 1194-8.
75. Cassarino DS, Swerdlow RH, Parks JK, Parker WD Jr, Bennett JP Jr. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem Biophys Res Commun 1998; 248: 168-73.
76. Cooper JM, Schapira AH. Mitochondrial dysfunction in neumdegeneration. J Bioenerg Biomembr 1997; 29: 175-83.
77. Thress K, Kombluth S, Smith JJ. Mitochondria at the crossroad of apoptotic cell death. J Bioenerg Biomembr 1999; 31: 321-6.
78. Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1998; 1: 366-73.
79. Rong Y, Doctrow SR, Tocco G, Baudry M. EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc Natl Acad Sci U S A 1999; 96: 9897-902.
80. Pong K, Doctrow SR, Huffman K, Adinolfi CA, Baudry M. Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons. Exp Neurol 2001; 171: 84-97.
81. Schinder, AF, Olson, EC, Spitzer, NC, Montal, M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1999; 16: 6125-33.
82. Camins A, Sureda FX, Gabriel C, Pallàs M, Escubedo E, Camarasa J. Modulation of neuronal mitochondrial membrane potential by the NMDA receptor: Role of arachidonic acid. Brain Res 1997; 777: 69-74.
83. Leventhal L, Sortwell CE, Hanbury R, Collier TJ, Kordower JH, Palfi S. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. J Comp Neurol 2000; 425: 471-8.
84. Nakatsuka H, Ohta S, Tanaka J, Toku K, Kumon Y, Maeda N, et al. Release of cytochrome c from mitochondria to cytosol in gerbil hippocampal CA1 neurons after transient forebrain ischemia. Brain Res 1999; 849: 216-9.